カテゴリ： GlobalData, アメリカ, 企業調査

Express Scripts Holding Co (ESRX)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Express Scripts Holding Co (ESRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C10044
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：64
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers’ compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.

Express Scripts Holding Co (ESRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Debt Offering 18
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 18
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 19
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 20
Acquisition 21
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 21
Express Scripts Holding Co – Key Competitors 23
Express Scripts Holding Co – Key Employees 24
Express Scripts Holding Co – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Strategy And Business Planning 28
Jul 18, 2018: Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis 28
Financial Announcements 29
Oct 31, 2018: Express Scripts announces 2018 third quarter results 29
Aug 01, 2018: Express Scripts announces 2018 second quarter results 31
May 02, 2018: Express Scripts Reports 2018 First Quarter Financial Results 33
Feb 27, 2018: Express Scripts Announces 2017 Fourth Quarter and Full Year Results 35
Oct 24, 2017: Express Scripts Announces 2017 Third Quarter Results 37
Jul 25, 2017: Express Scripts Announces 2017 Second Quarter Results 38
Apr 24, 2017: Express Scripts Announces 2017 First Quarter Results 39
Feb 14, 2017: Express Scripts Announces 2016 Fourth Quarter and Full Year Results 40
Corporate Communications 41
Oct 09, 2018: Express Scripts readies emergency support for impacted members in advance of Hurricane Michael 41
Sep 27, 2018: Cigna announces enterprise leadership team for combined company 42
Apr 03, 2018: Express Scripts appoints Ron Guerrier as chief information officer 43
Oct 24, 2017: Express Scripts Appoints James M. Havel Chief Financial Officer 44
Jun 27, 2017: Express Scripts Elects Kathleen M. Mazzarella to Board of Directors 45
Legal and Regulatory 46
Jun 25, 2018: Pharmacy First Files Suit Against Express Scripts 46
Jan 10, 2018: Express Scripts Accredo Earns Renewed URAC Specialty Pharmacy Accreditation 47
Government and Public Interest 48
May 11, 2018: Express Scripts Statement on Administration’s Comments on Drug Pricing 48
Aug 25, 2017: Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications 49
Product News 50
Nov 06, 2018: Express Script’ myMatrixx launches myDataSense analytics tool 50
Other Significant Developments 51
Oct 17, 2018: Express scripts offers new value-based program for migraine 51
Oct 09, 2018: Express Scripts Introduces Medicare Part D Plan Offerings for 2019 52
Sep 12, 2018: Express Scripts implements emergency procedures for affected members in advance of hurricane florence 53
May 10, 2018: Innovative Value-based SafeGuardRx Program Delivers Better Care at Lower Cost for Express Scripts’ Patients and Plan Sponsors 54
May 03, 2018: Inside Rx, a Prescription Savings Program from Express Scripts, Expands List of Discounted Brand-Name Medications 55
Apr 12, 2018: Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans 56
Feb 05, 2018: Inside Rx Provides Savings on Influenza Medications 57
Jan 11, 2018: Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients 58
Oct 02, 2017: Express Scripts Introduces New Medicare Part D Saver Plan for 2018 60
Jun 07, 2017: Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse 61
Jun 01, 2017: Express Scripts Expands SafeGuardRx Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis 62
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 18
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 19
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 20
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 21
Express Scripts Holding Co, Key Competitors 23
Express Scripts Holding Co, Key Employees 24
Express Scripts Holding Co, Subsidiaries 26

List of Figures
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Express Scripts Holding Co (ESRX)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Neovacs SA (ALNEV)：製薬・医療：M&Aディール及び事業提携情報
    Summary Neovacs SA (Neovacs) is a biotechnology company that develops various therapeutic vaccines for the treatment of autoimmune disorders, inflammatory diseases and cancers. The company offers TNF- kinoid and IFNalpha- kinoid products used for the treatment of rheumatoid arthritis, Crohn’s diseas …
  • Bharti Infratel Ltd：企業の戦略・SWOT・財務情報
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Corporacion Moctezuma, S.A.B. de C.V.：企業の戦略・SWOT・財務情報
    Corporacion Moctezuma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Corporacion Moctezuma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Federal-Mogul Holdings LLC：企業の戦略的SWOT分析
    Federal-Mogul Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kratos Defense & Security Solutions, Inc.：企業のM&A・事業提携・投資動向
    Kratos Defense & Security Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kratos Defense & Security Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • 4imprint Group plc (FOUR)：企業の財務・戦略的SWOT分析
    4imprint Group plc (FOUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Autobio Diagnostics Co Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Autobio Diagnostics Co Ltd (Autobio) is a clinical diagnostic company that provides research and development; production and distribution of clinical diagnostic products. The company provides products such as immunoassays, mycoplasma, blood culture bottle, bacterial vaginosis, microplate lum …
  • Cognition Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics to improve the lives of individuals with Alzheimer’s disease and other neurocognitive disorders. The company uses its proprietary biology and chemistry platf …
  • Kyokuyo Co., Ltd.
    Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyokuyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fabasoft Ag：企業の戦略・SWOT・財務分析
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • IMI plc：企業の戦略・SWOT・財務情報
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Pricer AB (PRIC B)：企業の財務・戦略的SWOT分析
    Pricer AB (PRIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oil States International Inc (OIS)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oil States International Inc (Oil States) is an oilfield services company. It offers specialty products and services to oil and natural gas companies. The company’s product portfolio includes subsea equipment and offshore vessel, rig equipment, flexible bearings, connection systems, subsea p …
  • Korean Air Lines Co Ltd
    Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Korean Air Lines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pentax Europe GmbH-医療機器分野：企業M&A・提携分析
    Summary Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp is a medical device company that provides clinical endo-imaging solutions. The company offers products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology, and urology. Its products in …
  • New York & Company, Inc.：企業の戦略・SWOT・財務情報
    New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Twist Bioscience Corp (TWST)：医療機器：M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Veritone, Inc. (VERI)：企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Environics Oy：企業の戦略・SWOT・財務情報
    Environics Oy - Strategy, SWOT and Corporate Finance Report Summary Environics Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dr. Reddy’s Research and Development BV-医療機器分野：企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆